Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 354
- Registration Number
- NCT02109562
- Locations
- 🇺🇸
Pillar Clinic Research, LLC, Dallas, Texas, United States
🇺🇸Comprehensive Clinical Development - Cerritos, CA, Cerritos, California, United States
🇺🇸Synergy Clinical Research of Escondido, Escondido, California, United States
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
- Conditions
- Interventions
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT02044094
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Overland Park, Kansas, United States
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
- Conditions
- Interventions
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT02038790
- Locations
- 🇺🇸
Hill Top Research, St Petersburg, Florida, United States
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
- Conditions
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01846481
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Overland Park,, Kansas, United States
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
- Conditions
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT01846455
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Inc., Hialeah, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸American Research Corporation (ARC), San Antonio, Texas, United States
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
- First Posted Date
- 2012-11-30
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT01738503
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Overland Park, Kansas, United States
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT01677377
- Locations
- 🇺🇸
Woodland International Research Group, Inc., Little Rock, Alaska, United States
🇺🇸Ocean View Psychiatric Health Facility, Long Beach, California, United States
Transfer of Subjects From Subutex/Suboxone to RBP-6300
- Conditions
- Interventions
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT01582347
- Locations
- 🇦🇹
Dr. Lindenbauer, Linz, Austria
🇩🇪Dr. Tietje, Bremen, Germany
🇨🇿Dr. Vehak, Prague, Czech Republic
Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
- Conditions
- Interventions
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT01075971
Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")
- Conditions
- Interventions
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT00955162
- Locations
- 🇫🇷
Csst Antibes, Antibes, France
🇫🇷Hopital Paul Guiraud, Bagneux, France
🇫🇷Centre Carreire , CH Charles Perrens, Bordeaux, France